Cargando…

Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients

PURPOSE: To investigate the clinical manifestations of orbital involvement in a large cohort of Chinese patients with IgG4-related disease (IgG4-RD). METHODS: A total of 573 patients with IgG4-related disease were included. We described and compared the demographic, clinical, laboratory and histopat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Linyang, Luo, Xuan, Fei, Yunyun, Peng, Linyi, Zhou, Jiaxin, Li, Jieqiong, Lu, Hui, Liu, Zheng, Zhang, Panpan, Liu, Xiaowei, Zhang, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711185/ https://www.ncbi.nlm.nih.gov/pubmed/34961492 http://dx.doi.org/10.1186/s12886-021-02210-z

Ejemplares similares

Long-Term Outcomes of IgG4-Related Ophthalmic Disease in a Chinese IgG4-Related Disease Cohort
por: Gan, Linyang, et al.
Publicado: (2021)

Single-Cell Sequencing of Immune Cell Heterogeneity in IgG4-Related Disease
por: Wu, Xunyao, et al.
Publicado: (2022)

IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
por: Peng, Linyi, et al.
Publicado: (2020)

Identifying clinical subgroups in IgG4-related disease patients using cluster analysis and IgG4-RD composite score
por: Li, Jieqiong, et al.
Publicado: (2020)

Different clinical patterns of IgG4-RD patients with and without eosinophilia
por: Zhang, Xia, et al.
Publicado: (2019)

Clinical characteristics and outcome of IgG4-related disease with hypocomplementemia: a prospective cohort study
por: Peng, Linyi, et al.
Publicado: (2021)

Peripheral B-Cell Immunophenotyping Identifies Heterogeneity in IgG4-Related Disease
por: Li, Jieqiong, et al.
Publicado: (2021)

Efficacy and safety of iguratimod plus corticosteroid as bridge therapy in treating mild IgG4‐related diseases: A prospective clinical trial
por: Zhang, Panpan, et al.
Publicado: (2019)

Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study
por: Zhou, Jiaxin, et al.
Publicado: (2020)

Potential impact of autoimmune diseases family history in IgG4-related disease: a retrospective cohort study
por: Sun, Ruijie, et al.
Publicado: (2023)

High-throughput sequencing of CD4(+) T cell repertoire reveals disease-specific signatures in IgG4-related disease
por: Wang, Liwen, et al.
Publicado: (2019)

Differential CpG DNA methylation of peripheral B cells, CD4(+) T cells, and salivary gland tissues in IgG4-related disease
por: Wu, Xunyao, et al.
Publicado: (2023)

Clinical features and treatment efficacy for IgG4-related thyroiditis
por: Han, Xinxin, et al.
Publicado: (2021)

IgG4-related Ophthalmic Disease with Proptosis
por: Matsuhisa, Takaharu, et al.
Publicado: (2019)

Correction to: Clinical features and treatment efficacy for IgG4-related thyroiditis
por: Han, Xinxin, et al.
Publicado: (2021)

IgG4-related ophthalmic disease involving extraocular muscles: case series
por: Kim, Namju, et al.
Publicado: (2018)

Pathological count of IgG4-positive plasmacytes suggests extraophthalmic involvement and relapse in patients with IgG4-related ophthalmic disease: a retrospective study
por: Yuan, Yiqun, et al.
Publicado: (2022)

Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients
por: Wang, Liwen, et al.
Publicado: (2018)

Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China
por: Tang, Hanqi, et al.
Publicado: (2020)

Immunological mechanism of IgG4-related disease
por: Liu, Changyan, et al.
Publicado: (2020)

Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
por: Gan, Linyang, et al.
Publicado: (2023)

IgG4-Related Ophthalmic Disease Presenting as Meningitis and Panuveitis
por: Mavrommatis, Maria A., et al.
Publicado: (2019)

Long-Term Follow-Up in IgG4-Related Ophthalmic Disease: Serum IgG4 Levels and Their Clinical Relevance
por: Chou, Wei-Yi, et al.
Publicado: (2022)

Aberrant Expansion and Function of Follicular Helper T Cell Subsets in IgG4‐Related Disease
por: Chen, Yu, et al.
Publicado: (2018)

Differences and similarities between IgG4-related disease with and without dacryoadenitis and sialoadenitis: clinical manifestations and treatment efficacy
por: Wang, Mu, et al.
Publicado: (2019)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

The evaluation of IgG4 and IgG expression in cutaneous Rosai-Dorfman disease()
por: Zou, Puyu, et al.
Publicado: (2023)

Efficacy and safety of intravenous glucocorticoid therapy for IgG4-related ophthalmic disease
por: Yang, Min Kyu, et al.
Publicado: (2023)

TSLP promoting B cell proliferation and polarizing follicular helper T cell as a therapeutic target in IgG4-related disease
por: Lu, Hui, et al.
Publicado: (2022)

Disparities between IgG4-related kidney disease and extrarenal IgG4-related disease in a case–control study based on 450 patients
por: Zeng, Qiaozhu, et al.
Publicado: (2021)

Magnetic resonance imaging indicator of the causes of optic neuropathy in IgG4-related ophthalmic disease
por: Li, Jing, et al.
Publicado: (2019)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Longstanding IgG4-related Ophthalmic Disease Dramatically Improved after Steroid Therapy
por: Hirata, Yoko, et al.
Publicado: (2018)

Image-Guided Intensity-Modulated Radiation Therapy for IgG4-Related Ophthalmic Disease
por: Sabol, Rachel A., et al.
Publicado: (2020)

Comprehensive Gene Analysis of IgG4-Related Ophthalmic Disease Using RNA Sequencing
por: Asakage, Masaki, et al.
Publicado: (2020)

Long-term outcomes of ocular adnexal lesions in IgG4-related ophthalmic disease
por: Kubota, Toshinobu, et al.
Publicado: (2020)

Cases with IgG4-related ophthalmic disease with mass lesions surrounding the optic nerve
por: Hamaoka, Shoko, et al.
Publicado: (2022)

Enriched blood IgG sialylation attenuates IgG-mediated and IgG-controlled-IgE-mediated allergic reactions
por: Petry, Janina, et al.
Publicado: (2020)

Association of dengue infection with anti-alpha-gal antibodies, IgM, IgG, IgG1, and IgG2
por: Olajiga, Olayinka M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j4k1546l12t7fp3p309a0j48u4